Top

Archives of Gynecology and Obstetrics

Published in:

01-01-2014 | Maternal-Fetal Medicine

The prevalence of non-detectable chromosomal abnormalities by QF-PCR in amniocentesis for certain referral indications: experience at a mainland Chinese hospital

Authors: Can Liao, Cui-Xing Yi, Fa-Tao Li, Dong-Zhi Li

Published in: Archives of Gynecology and Obstetrics | Issue 1/2014

Abstract

Purpose

To study the prevalence of non-detectable chromosomal abnormalities by quantitative fluorescent polymerase chain reaction (QF-PCR) in a Chinese population referred for amniocentesis.

Methods

The karyotype results were reviewed in 8,466 amniotic fluid cultures performed for positive fetal Down syndrome screening or advanced maternal age between January 2002 and June 2012. The karyotype results were classified as detectable or not detectable by QF-PCR, using the assumption that all tests were conducted by this rapid molecular method.

Results

Of the 8,466 karyotypes obtained, 211 abnormal karyotypes were found (2.5 %). Out of these, 168 cases of common aneuploidies were identified by QF-PCR, and 43 cases of chromosomal abnormalities were missed. The 43 cases missed by QF-PCR included 31 cases predicted to confer no increased risk and 12 with a potential clinical significance. When QF-PCR shows a normal result, the overall residual risk is 0.1 % for any clinically significant chromosomal abnormality.

Conclusions

A normal QF-PCR result predicts a very low residual risk for patients who are referred solely for an increased risk of a common trisomy.

Mann K, Ogilvie CM (2012) QF-PCR: application, overview and review of the literature. Prenat Diagn 32:309–314PubMedCrossRef

Langlois S, Duncan A (2011) Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies. J Obstet Gynaecol Can 33:955–960PubMed

Faas BH, Cirigliano V, Bui TH (2011) Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies. Semin Fetal Neonatal Med 16:81–87PubMedCrossRef

Shaffer LG, Bui TH (2007) Molecular cytogenetic and rapid aneuploidy detection methods in prenatal diagnosis. Am J Med Genet C Semin Med Genet 145C:87–98PubMedCrossRef

Nicolini U, Lalatta F, Natacci F, Curcio C, Bui TH (2004) The introduction of QF-PCR in prenatal diagnosis of fetal aneuploidies: time for reconsideration. Hum Reprod Update 10:541–548PubMedCrossRef

Leung WC, Lau ET, Lao TT, Tang MH (2003) Can amnio-polymerase chain reaction alone replace conventional cytogenetic study for women with positive biochemical screening for fetal Down syndrome? Obstet Gynecol 101:856–861PubMedCrossRef

Speevak MD, McGowan-Jordan J, Chun K (2011) The detection of chromosome anomalies by QF-PCR and residual risks as compared to G-banded analysis. Prenat Diagn 31:454–458PubMedCrossRef

Comas C, Echevarria M, Carrera M, Serra B (2010) Rapid aneuploidy testing versus traditional karyotyping in amniocentesis for certain referral indications. J Matern Fetal Neonatal Med 23:949–955PubMedCrossRef

Caine A, Maltby AE, Parkin CA et al (2005) Prenatal detection of Down’s syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment. Lancet 366:123–128PubMedCrossRef

10.

Gekas J, van den Berg DG, Durand A et al (2011) Rapid testing versus karyotyping in Down’s syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities. Eur J Hum Genet 19:3–9PubMedCrossRef

11.

Ogilvie CM, Lashwood A, Chitty L, Waters JJ, Scriven PN, Flinter F (2005) The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down’s syndrome testing. BJOG 112:1369–1375PubMedCrossRef

12.

Hills A, Donaghue C, Waters J et al (2010) QF-PCR as a stand-alone test for prenatal samples: the first 2 years’ experience in the London region. Prenat Diagn 30:509–517PubMed

13.

Papoulidis I, Siomou E, Sotiriadis A et al (2012) Dual testing with QF-PCR and karyotype analysis for prenatal diagnosis of chromosomal abnormalities. Evaluation of 13,500 cases with consideration of using QF-PCR as a stand-alone test according to referral indications. Prenat Diagn 32:680–685PubMedCrossRef

14.

Ried T, Landes G, Dackowski W, Klinger K, Ward DC (1992) Multicolor fluorescence in situ hybridization for the simultaneous detection of probe sets for chromosomes 13, 18, 21, X and Y in uncultured amniotic fluid cells. Hum Mol Genet 1:307–313PubMedCrossRef

15.

Leung WC, Lam YH, Wong Y, Lau ET, Tang MHY (2002) The effect of fast reporting by amnio-PCR on anxiety levels in women with positive biochemical screening for Down syndrome: a randomized controlled trial. Prenat Diagn 22:256–259PubMedCrossRef

16.

Leung WC, Lau ET, Ngai C et al (2008) A prospective study on the effect of rapid aneuploidy testing (amnio-PCR) on anxiety levels and quality of life measures in women and their partners with positive Down screening result. Fetal Diagn Ther 24:165–169PubMedCrossRef

17.

Lam YH, Tang MH, Sin SY, Ghosh A (1998) Clinical significance of amniotic-fluid-cell culture failure. Prenat Diagn 18:343–347PubMedCrossRef

Title: The prevalence of non-detectable chromosomal abnormalities by QF-PCR in amniocentesis for certain referral indications: experience at a mainland Chinese hospital
Authors: Can Liao
Cui-Xing Yi
Fa-Tao Li
Dong-Zhi Li
Publication date: 01-01-2014
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 1/2014
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-013-2951-4

At a glance: The STEP trials

Springer Medicine

The prevalence of non-detectable chromosomal abnormalities by QF-PCR in amniocentesis for certain referral indications: experience at a mainland Chinese hospital

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Membrane stripping to prevent post-term pregnancy in Enugu, Nigeria: a randomized controlled trial

Robotic surgery in gynecology

Blastocyst formation, pregnancy and birth (more than 10 years after the birth of the first child from the same IVF cycle), derived from human PN-stage cryopreserved for 10 years

Value of follicular fluid vitamin D in predicting the pregnancy rate in an IVF program

Bethlem myopathy: pregnancy and delivery

Assessment of bowel function in the peripartum period